98%
921
2 minutes
20
The aim of this study was to develop and evaluate the transdermal patch formulations of nifedipine. The patch formulations containing nifedipine were prepared and optimized with different ratios of vinyl and cellulose-derived polymers, drug contents, and permeation enhancers. Among the various formulations, the patch formulation containing a 1:5 ratio of ethyl cellulose and polyvinyl pyrrolidone was selected for pharmacokinetic study based on permeation studies using stratum corneum of the pig's skin. The cumulative percentage release after the transdermal administration of the optimized patch formulation was 71.43%, and the plasma concentration of nifedipine was maintained for 16 hrs. The physicochemical evaluation study including flatness, thickness, moisture content and uptake, drug content release, and permeation indicated satisfactory results. The formulation batch with clove oil as a penetration enhancer has shown better permeation as compared to the formulations without enhancers and another synthetic enhancer. These results suggest that the optimized patch formulation Q3 could be further developed for clinical applications, providing the therapeutic plasma level of nifedipine over an extended period. Hence analyzing the results of the evaluation tests, and data on the preparation and optimization of nifedipine-loaded transdermal patch, it can be concluded that the formulation shows its feasibility as an effective transdermal delivery system for nifedipine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09205063.2024.2330682 | DOI Listing |
Adv Pharm Bull
July 2025
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal- 576104, India.
Purpose: The present study aimed to fabricate microneedles (MNs) for transdermal delivery of insulin. Chitosan-conjugated carboxy phenyl boronic acid polymer was synthesized and characterized to load insulin in the form of nanoparticles.
Methods: Optimized insulin nanoparticles (ILN-NPs) were loaded into MN arrays by micromolding, and the resulting MN patches were characterized by scanning electron microscopy (SEM) and mechanical failure tests.
Eur J Pharm Biopharm
September 2025
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, PR China. Electronic address:
Iguratimod (IGU) is a novel anti-rheumatic drug, which has anti-inflammatory effects, inhibits bone destruction, and promotes bone formation. However, the gastrointestinal side-effects caused by oral tablets of IGU pose a challenge. This study aimed to develop an IGU transdermal patch for Rheumatoid Arthritis (RA) through ion-pair and chemical penetrant strategies to improve the therapeutic efficacy.
View Article and Find Full Text PDFAdv Healthc Mater
September 2025
Department of Smart Health Science and Technology, Kangwon National University (KNU), 1, Kangwondaehak-gil, Chuncheon-si, Gangwon-do, Republic of Korea.
Microneedle (MN) technology offers a minimally invasive, patient-friendly alternative to conventional hypodermic injections for dermal drug delivery. However, traditional micro-molding techniques are limited by single-material fabrication, involving labor-intensive processes, excessive material waste, and scalability issues, restricting broader therapeutic applications. To address these challenges, an inkjet printing method is implemented to fabricate multi-material MN patches using gelatin and gelatin methacryloyl (GelMA) hydrogels.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
School of Science, Technology and Engineering, University of the Sunshine Coast, Petrie, Queensland, Australia.
Drug release using polymeric microneedles (MNs) plays a significant role in medical applications and the treatment of various diseases. However, conventional MNs are often limited by complex fabrication procedures and inadequate mechanical strength. This study introduces a dual-function core/shell MN patch fabricated through a novel method that integrates 3D printing and casting techniques.
View Article and Find Full Text PDFBiosens Bioelectron
December 2025
Antwerp Engineering, Photoelectrochemistry and Sensing (A-PECS), University of Antwerp, Groenenborgerlaan 171, 2020, Antwerp, Belgium; NANOlight Center of Excellence, University of Antwerp, Groenenborgerlaan 171, 2010, Antwerp, Belgium. Electronic address:
Microneedle-based electrochemical sensors (MES) are developed as interface systems between the sensor and interstitial fluid (ISF), allowing the transdermal monitoring of analytes with clinical value. However, the widespread adoption of MES platforms to enable advances in devices for health monitoring is still a challenge. Herein, we propose an affordable and versatile wearable patch based on 3D-printed microneedle arrays to facilitate the development of electrochemical sensors.
View Article and Find Full Text PDF